Jun. 29 at 1:34 PM
Reminder: If you bought
$BTAI, tomorrow is the deadline to file a claim in the
$9.75M investor settlement.
If you purchased shares between 2023 and 2023, you may be eligible. The settlement claims that BioXcel misled investors about internal controls, protocol compliance, and data integrity in its Phase 3 TRANQUILITY II clinical trial. After the company disclosed FDA inspection findings and protocol violations,
$BTAI dropped nearly 64%.
You can check your eligibility and submit your claim before the deadline:https://11th.com/cases/bioxcel-investor-settlement
